Pharmaceutical & Drug Policy
Response to Senate Finance Committee request for information on policies for lowering drug prices
Pharmaceutical & Drug Policy
Comments on the Medicare Drug Price Negotiation Program proposed rule for IPAY 2029
Public Health
Exploring the sources of the decline in US drug overdoses
Pharmaceutical & Drug Policy
Comments on DEA’s proposed rule on manufacturing and procurement quotas
Experts
Vanda Felbab-Brown
Director
- Initiative on Nonstate Armed Actors,
Co-Director
- Africa Security Initiative,
Senior Fellow
- Foreign Policy, Strobe Talbott Center for Security, Strategy, and Technology
Ryan Conrad
Visiting Fellow
- Economic Studies, Center on Health Policy